Respiratory failure & ventilation

Breathlessness assessment, management and impact in the intensive care unit: a rapid review and narrative synthesis

Ann Intensive CarePublished Rapid review and narrative synthesis

Authors' conclusion

Breathlessness in adults receiving IMV, NIV or HFOT in the ICU is prevalent and clinically important with median intensity ratings indicating the presence of moderate to severe symptoms.

Study context

Population
Adults in the intensive care unit (ICU) receiving invasive mechanical ventilation (IMV), NIV or high-flow oxygen therapy (HFOT)
Participants
2,822 adults · 19 studies
Outcome
Prevalence, intensity, assessment and management of breathlessness; impact on engagement with rehabilitation
Methodological detailsCochrane Methods Group Recommendations, PRISMA reporting, quality appraised, Searched PubMed, MEDLINE, Cochrane Library, CINAHL, June 2013 to June 2023
  • Cochrane Methods Group Recommendations
  • PRISMA reporting
  • Quality appraised
  • Searched PubMed, MEDLINE, Cochrane Library, CINAHL, June 2013 to June 2023

Main finding

As reported in the abstract

Breathlessness prevalence and intensity
Weighted mean prevalence of breathlessness, IMV (range 34-66%)
49%
Moderate to severe dyspnoea before NIV initiation
55%
Highest reported median (IQR) visual analogue scale (VAS), NIV
6.2cm (0-10 cm)
Highest reported median (IQR) numerical rating scale (NRS), NIV
5 (2-7)
Highest reported median (IQR) mBORG, NIV
6 (2.3-7)
Highest reported median (IQR) VAS, NIV or HFOT
3 cm (0-6 cm)
Highest reported median (IQR) NRS, NIV or HFOT
8 (5-10)
Highest reported median (IQR) mBORG, NIV or HFOT
4 (3-5)

Further findings

Assessment tools

VAS, NRS and modified BORG scale (mBORG) used

Original publication

Breathlessness assessment, management and impact in the intensive care unit: a rapid review and narrative synthesis. Ann Intensive Care. Published 5 July 2024. doi:10.1186/s13613-024-01338-7

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.